查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930082

全球生物感测器市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034）

Biosensors Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 162 Pages | 商品交期: 请询问到货日

价格

生物感测器市场成长因素

受医疗和非医疗领域对快速、准确和微创诊断解决方案的需求不断增长的推动，全球生物感测器市场正经历强劲增长。 根据 Fortune Business Insights 预测，生物感测器市场规模预计将在 2025 年达到 298.8 亿美元，并在 2026 年达到 326 亿美元。在临床诊断、健康监测和即时检测等领域的日益普及推动下，该市场预计将在 2026 年至 2034 年间以 9.44% 的复合年增长率增长，到 2034 年达到 671 亿美元。

北美地区拥有先进的医疗基础设施、慢性病高发生率以及穿戴式装置和即时诊断技术的广泛应用，预计将在 2025 年占全球生物感测器市场 44.53% 的占有率。

市场概览

生物感测器是一种分析设备，可以将来自酵素、细胞和组织的生物反应转化为可测量的电讯号。 它们被广泛应用于医疗诊断、农业、环境监测、食品安全和生物医学研究等领域。在医疗保健领域，生物感测器能够实现疾病的早期检测、持续监测和无痛诊断，使其成为现代临床实践中不可或缺的工具。

全球糖尿病、心血管疾病和传染病负担的日益加重，显着推动了对基于生物感测器的医疗设备的需求。此外，半导体製造商和医疗设备製造商之间的合作正在加速高精度生物感测器平台的开发，进一步促进市场成长。

新冠疫情的影响

2020年，新冠疫情加速了从集中式实验室诊断向即时检测和居家检测的转变，从而对生物感测器市场产生了积极影响。即使在疫情后时期，自测和穿戴式生物感测器设备的持续普及，也为2021年及以后的市场成长提供了支撑。 生物感测器在快速诊断、疾病监测和远端患者监护方面发挥了关键作用。

生物感测器市场趋势

生物感测器在糖尿病监测中的应用日益广泛

生物感测器市场最显着的趋势之一是糖尿病监测设备的日益普及。采用电化学生物感测器的连续血糖监测 (CGM) 系统在医院和家庭医疗保健机构的应用越来越广泛。这些设备能够实现即时监测、改善胰岛素管理并提高患者的便利性。

据雅培公司称，2021 年全球将有超过 300 万人使用 FreeStyle Libre CGM 系统，这反映出市场对基于生物感测器的糖尿病解决方案的强劲需求。持续进行旨在将胰岛素监测生物感测器与血糖感测器整合的研究和开发工作，预计将进一步扩大其应用范围。

市场成长驱动因素

生物感测器技术进步

奈米材料、石墨烯基感测器、萤光标记和光纤技术的快速发展显着提高了生物感测器的灵敏度、选择性和准确性。这些创新正在拓展生物感测器的应用领域，包括药物研发、癌症诊断和传染病检测。

例如，2022年1月，IDENTIFYSENSORS公司开发了一种基于石墨烯的SARS-CoV-2生物感测器，其灵敏度约为96.0%，凸显了先进材料在下一代诊断技术中的重要作用。

限制因子

儘管市场成长潜力巨大，但仍面临生产成本高、感测器稳定性有限和设备寿命短等挑战。 感测器效能下降、漂移以及频繁更换零件等问题可能会限制其长期应用，尤其是在资源有限的环境中。

市场区隔分析

依类型

市场可细分为电化学生物感测器、光学生物感测器、压电生物感测器和其他类型。

受血糖监测设备广泛应用的推动，电化学生物感测器预计将占市场主导地位，到2026年将占80.60%的市场占有率。由于对非侵入式诊断的需求不断增长，光学生物感测器预计将呈现最快的增长速度。

依应用

依应用划分，市场包括临床诊断、健康监测和其他领域。

受全球即时诊断（POC）检测成长的推动，临床诊断领域预计在2026年将占最大的市场占有率，达到67.22%。

依最终使用者划分

市场依最终用户分为医疗器材製造商、合约研发生产机构（CDMO）及其他。

医疗器材製造商在强劲的产品开发举措和对配备生物感测器的医疗器材日益增长的需求的推动下，预计将在2026年占73.14%的市场占有率，成为市场主导者。

区域因素

受持续的产品发布和监管审批的推动，北美生物感测器市场预计将在2025年增长至133亿美元，并在2026年增长至144.7亿美元。

由于欧洲拥有雄厚的医疗研究资金和生物感测器研发（R&D）实力，欧洲占了很大比例。

亚太地区预计将实现最高成长率，这主要得益于糖尿病患者数量的增加以及即时诊断技术的日益普及。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要公司研发支出概况（2025 年）
  • 生物感测器技术进步概览
  • 关键产业趋势：併购、业务伙伴关係
  • 新产品发布
  • 新冠疫情对市场的影响

第五章 全球生物感测器市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依类型划分
    • 电化学生物感测器
    • 光学生物感测器
    • 压电生物感测器
    • 其他
  • 市场分析、洞察与预测：依应用划分
    • 临床诊断
      • 血糖监测
      • 传染病筛检
      • 怀孕与不孕症检测
      • 其他
    • 健康监测
      • 生命征象监测
      • 活动监测
    • 其他
  • 市场分析，洞察与预测：依最终用户划分
    • 医疗器材製造商
    • CDMO（合约开发与生产组织）
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美生物感测器市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲生物感测器市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国王国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲国家

第八章 亚太生物感测器市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 澳大利亚
    • 中国
    • 印度
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲生物感测器市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章 中东与非洲生物感测器市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
    • Abbott
    • Medtronic
    • F. Hoffmann-La Roche Ltd.
    • Universal Biosensors
    • DuPont
    • Biosensors International Group, Ltd.
    • Bio-Rad Laboratories Inc.
    • Koninklijke Philips N.V.
    • LifeScan IP Holdings, LLC
    • Molecular Devices, LLC.
Product Code: FBI100146

Growth Factors of biosensors Market

The global biosensors market is witnessing strong growth due to rising demand for rapid, accurate, and minimally invasive diagnostic solutions across healthcare and non-healthcare applications. According to Fortune Business Insights, the biosensors market size was valued at USD 29.88 billion in 2025 and is projected to grow to USD 32.60 billion in 2026. With expanding adoption across clinical diagnostics, health monitoring, and point-of-care testing, the market is forecasted to reach USD 67.10 billion by 2034, exhibiting a CAGR of 9.44% during the 2026-2034 forecast period.

North America dominated the global biosensors market with a 44.53% share in 2025, supported by advanced healthcare infrastructure, high prevalence of chronic diseases, and strong adoption of wearable and point-of-care diagnostic technologies.

Market Overview

Biosensors are analytical devices that convert biological responses from enzymes, cells, or tissues into measurable electrical signals. These devices are widely used across medical diagnostics, agriculture, environmental monitoring, food safety, and biomedical research. In healthcare, biosensors enable early disease detection, continuous monitoring, and pain-free diagnostics, making them essential tools in modern clinical practice.

The increasing global burden of diabetes, cardiovascular diseases, and infectious disorders has significantly boosted demand for biosensor-based medical devices. Additionally, collaborations between semiconductor manufacturers and medical device companies are accelerating the development of highly precise biosensor platforms, further driving market growth.

Impact of COVID-19

The COVID-19 pandemic positively influenced the biosensors market in 2020 by accelerating the shift from centralized laboratory diagnostics to point-of-care and home-based testing. Increased adoption of self-testing and wearable biosensor-enabled devices continued during the post-pandemic period, supporting market growth in 2021 and beyond. Biosensors played a critical role in rapid diagnosis, disease surveillance, and remote patient monitoring.

Biosensors Market Trends

Rising Adoption of Biosensors for Diabetes Monitoring

One of the most prominent trends in the biosensors market is the growing deployment of devices for diabetes monitoring. Continuous glucose monitoring (CGM) systems using electrochemical biosensors are increasingly adopted across hospitals and homecare settings. These devices offer real-time monitoring, improved insulin management, and enhanced patient convenience.

According to Abbott, more than 3.0 million people worldwide were using the FreeStyle Libre CGM system in 2021, reflecting strong demand for biosensor-enabled diabetes solutions. Ongoing R&D efforts aimed at integrating insulin-monitoring biosensors with glucose sensors are expected to further strengthen adoption.

Market Growth Factors

Technological Advancements in Biosensors

Rapid advancements in nanomaterials, graphene-based sensors, fluorescence tagging, and fiber-optic technologies are significantly improving biosensor sensitivity, selectivity, and accuracy. These innovations are expanding biosensor applications across drug discovery, cancer diagnostics, and infectious disease testing.

For example, in January 2022, IDENTIFYSENSORS developed a graphene-based SARS-CoV-2 biosensor with approximately 96.0% sensitivity, highlighting the role of advanced materials in next-generation diagnostics.

Restraining Factors

Despite strong growth potential, the market faces challenges such as high production costs, limited sensor stability, and short device lifespan. Issues related to sensor degradation, drift, and frequent component replacement can restrict long-term adoption, particularly in resource-limited settings.

Segmentation Analysis

By Type

The market is segmented into electrochemical biosensors, optical biosensors, piezoelectric biosensors, and others.

Electrochemical biosensors dominated the market with an 80.60% share in 2026, driven by widespread adoption of glucose monitoring devices. Optical biosensors are expected to grow at the fastest rate due to increasing demand for non-invasive diagnostics.

By Application

Based on application, the market includes clinical diagnostics, health monitoring, and others.

The clinical diagnostics segment held the largest share of 67.22% in 2026, supported by the rising number of point-of-care diagnostic tests worldwide.

By End User

By end user, the market is segmented into medical device companies, CDMOs, and others.

Medical device companies dominated the market with a 73.14% share in 2026, owing to strong product development initiatives and growing demand for biosensor-enabled healthcare devices.

Regional Insights

The North America biosensors market was valued at USD 13.30 billion in 2025 and increased to USD 14.47 billion in 2026, driven by continuous product launches and regulatory approvals.

Europe held a significant share due to strong healthcare research funding and biosensor R&D initiatives.

Asia Pacific is expected to record the highest growth rate, supported by rising diabetes prevalence and increasing adoption of point-of-care diagnostics.

Competitive Landscape

The biosensors market is dominated by key players such as Abbott, Medtronic, F. Hoffmann-La Roche Ltd., DuPont, Universal Biosensors, and Koninklijke Philips N.V. These companies focus on strategic collaborations, product launches, and technological innovation to strengthen their global presence.

Conclusion

In conclusion, the global biosensors market, valued at USD 29.88 billion in 2025, is projected to grow to USD 32.60 billion in 2026 and further reach USD 67.10 billion by 2034. Growth is driven by rising chronic disease prevalence, technological advancements, and expanding adoption of point-of-care and home-based diagnostic solutions.

Growth Rate CAGR of 9.44% from 2026-2034

Segmentation By Type

  • Electrochemical Biosensors
  • Optical Sensors
  • Piezoelectric Sensors
  • Others

By Application

  • Clinical Diagnostics
    • Glucose Monitoring
    • Infectious Disease Screening
    • Pregnancy & Fertility Testing
    • Others
  • Health Monitoring
    • Vital Signs Monitoring
    • Activity Tracking
  • Others

By End User

  • Medical Device Companies
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Others

By Region

  • North America (By Type, By Application, By End User and By Country)
    • U.S.
    • Canada
  • Europe (By Type, By Application, By End User and By Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Type, By Application, By End User and By Country/Sub-region)
    • Japan
    • China
    • India
    • Southeast Asia
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, By Application, By End User and By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Application, By End User and By Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of R&D Expenditure, Key Players, 2025
  • 4.2. Overview: Technological Advancements in Biosensors
  • 4.3. Key Industry Developments - Partnerships, Mergers & Acquisitions
  • 4.4. New Product Launches
  • 4.5. Impact of COVID-19 on the Market

5. Global Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Electrochemical Biosensors
    • 5.1.2. Optical Biosensors
    • 5.1.3. Piezoelectric Biosensors
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Clinical Diagnostics
      • 5.2.1.1. Glucose Monitoring
      • 5.2.1.2. Infectious Disease Screening
      • 5.2.1.3. Pregnancy & Fertility Testing
      • 5.2.1.4. Others
    • 5.2.2. Health Monitoring
      • 5.2.2.1. Vital Signs Monitoring
      • 5.2.2.2. Activity Tracking
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Medical Device Companies
    • 5.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Electrochemical Biosensors
    • 6.1.2. Optical Biosensors
    • 6.1.3. Piezoelectric Biosensors
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Clinical Diagnostics
      • 6.2.1.1. Glucose Monitoring
      • 6.2.1.2. Infectious Disease Screening
      • 6.2.1.3. Pregnancy & Fertility Testing
      • 6.2.1.4. Others
    • 6.2.2. Health Monitoring
      • 6.2.2.1. Vital Signs Monitoring
      • 6.2.2.2. Activity Tracking
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Medical Device Companies
    • 6.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 6.3.3. Others
  • 6.4. Market Analysis - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Electrochemical Biosensors
    • 7.1.2. Optical Biosensors
    • 7.1.3. Piezoelectric Biosensors
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Clinical Diagnostics
      • 7.2.1.1. Glucose Monitoring
      • 7.2.1.2. Infectious Disease Screening
      • 7.2.1.3. Pregnancy & Fertility Testing
      • 7.2.1.4. Others
    • 7.2.2. Health Monitoring
      • 7.2.2.1. Vital Signs Monitoring
      • 7.2.2.2. Activity Tracking
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Medical Device Companies
    • 7.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 7.3.3. Others
  • 7.4. Market Analysis - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Rest of Europe

8. Asia pacific Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Electrochemical Biosensors
    • 8.1.2. Optical Biosensors
    • 8.1.3. Piezoelectric Biosensors
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Clinical Diagnostics
      • 8.2.1.1. Glucose Monitoring
      • 8.2.1.2. Infectious Disease Screening
      • 8.2.1.3. Pregnancy & Fertility Testing
      • 8.2.1.4. Others
    • 8.2.2. Health Monitoring
      • 8.2.2.1. Vital Signs Monitoring
      • 8.2.2.2. Activity Tracking
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Medical Device Companies
    • 8.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 8.3.3. Others
  • 8.4. Market Analysis - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. Australia
    • 8.4.3. China
    • 8.4.4. India
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Electrochemical Biosensors
    • 9.1.2. Optical Biosensors
    • 9.1.3. Piezoelectric Biosensors
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Clinical Diagnostics
      • 9.2.1.1. Glucose Monitoring
      • 9.2.1.2. Infectious Disease Screening
      • 9.2.1.3. Pregnancy & Fertility Testing
      • 9.2.1.4. Others
    • 9.2.2. Health Monitoring
      • 9.2.2.1. Vital Signs Monitoring
      • 9.2.2.2. Activity Tracking
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Medical Device Companies
    • 9.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Electrochemical Biosensors
    • 10.1.2. Optical Biosensors
    • 10.1.3. Piezoelectric Biosensors
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Clinical Diagnostics
      • 10.2.1.1. Glucose Monitoring
      • 10.2.1.2. Infectious Disease Screening
      • 10.2.1.3. Pregnancy & Fertility Testing
      • 10.2.1.4. Others
    • 10.2.2. Health Monitoring
      • 10.2.2.1. Vital Signs Monitoring
      • 10.2.2.2. Activity Tracking
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Medical Device Companies
    • 10.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Abbott
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Medtronic
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. F. Hoffmann-La Roche Ltd.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Universal Biosensors
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. DuPont
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Biosensors International Group, Ltd.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Bio-Rad Laboratories Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Koninklijke Philips N.V.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. LifeScan IP Holdings, LLC
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Molecular Devices, LLC.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 4: Global Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 5: Global Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 6: Global Biosensors Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 8: North America Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 9: North America Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 10: North America Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 11: North America Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: North America Biosensors Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Europe Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Europe Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 16: Europe Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 17: Europe Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 18: Europe Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 20: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 21: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 22: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 23: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 24: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 26: Latin America Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Latin America Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 28: Latin America Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 29: Latin America Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Latin America Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 32: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 33: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 34: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 35: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 36: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Biosensors Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Biosensors Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Biosensors Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Biosensors Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Biosensors Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Biosensors Market Value Share (%), by Type, 2025
  • Figure 8: North America Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Biosensors Market Value Share (%), by Application, 2025
  • Figure 10: North America Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Biosensors Market Value Share (%), by End-user, 2025
  • Figure 12: North America Biosensors Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Biosensors Market Value Share (%), By Country, 2025
  • Figure 14: Europe Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Biosensors Market Value Share (%), by Type, 2025
  • Figure 16: Europe Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Biosensors Market Value Share (%), by Application, 2025
  • Figure 18: Europe Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Biosensors Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Biosensors Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Biosensors Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Biosensors Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Biosensors Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Biosensors Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Biosensors Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Biosensors Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Biosensors Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Biosensors Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Biosensors Market Share (%), By Company, 2025